DCBO.TO Quote, Financials, Valuation and Earnings

Constellation Software has a net margin of 8.95% compared to Docebo's net margin of 6.45%. Docebo's return on equity of 27.19% beat Constellation Software's return on equity of 23.25%.

Docebo has a consensus price target of $76.17, signalling upside risk potential of 21.59%. On the other hand Constellation Software has an analysts' consensus of $4,973.96 which suggests that it could grow by 19.49%. Given that Docebo has higher upside potential than Constellation Software, analysts believe Docebo is more attractive than Constellation Software.

Docebo has a beta of 1.384, which suggesting that the stock is 38.423% more volatile than S&P 500. In comparison Constellation Software has a beta of 0.881, suggesting its less volatile than the S&P 500 by 11.95%.

Docebo has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Constellation Software offers a yield of 0.13% to investors and pays a quarterly dividend of $1.44 per share. Docebo pays -- of its earnings as a dividend. Constellation Software pays out 15.04% of its earnings as a dividend. Constellation Software's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Docebo quarterly revenues are $75.6M, which are smaller than Constellation Software quarterly revenues of $3.5B. Docebo's net income of $6.8M is lower than Constellation Software's net income of $223.8M. Notably, Docebo's price-to-earnings ratio is 78.81x while Constellation Software's PE ratio is 110.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Docebo is 7.05x versus 6.69x for Constellation Software. Usually stocks with elevated PS ratios are considered overvalued.

Kinaxis has a net margin of 8.95% compared to Docebo's net margin of 5.56%. Docebo's return on equity of 27.19% beat Kinaxis's return on equity of 4.66%.

Docebo has a consensus price target of $76.17, signalling upside risk potential of 21.59%. On the other hand Kinaxis has an analysts' consensus of $198.29 which suggests that it could grow by 16.58%. Given that Docebo has higher upside potential than Kinaxis, analysts believe Docebo is more attractive than Kinaxis.

Docebo has a beta of 1.384, which suggesting that the stock is 38.423% more volatile than S&P 500. In comparison Kinaxis has a beta of 0.788, suggesting its less volatile than the S&P 500 by 21.189%.

Docebo has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kinaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Docebo pays -- of its earnings as a dividend. Kinaxis pays out -- of its earnings as a dividend.

Docebo quarterly revenues are $75.6M, which are smaller than Kinaxis quarterly revenues of $165.8M. Docebo's net income of $6.8M is lower than Kinaxis's net income of $9.2M. Notably, Docebo's price-to-earnings ratio is 78.81x while Kinaxis's PE ratio is 179.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Docebo is 7.05x versus 7.70x for Kinaxis. Usually stocks with elevated PS ratios are considered overvalued.

Nerds On Site has a net margin of 8.95% compared to Docebo's net margin of -9.88%. Docebo's return on equity of 27.19% beat Nerds On Site's return on equity of --.

Docebo has a consensus price target of $76.17, signalling upside risk potential of 21.59%. On the other hand Nerds On Site has an analysts' consensus of -- which suggests that it could fall by --. Given that Docebo has higher upside potential than Nerds On Site, analysts believe Docebo is more attractive than Nerds On Site.

Docebo has a beta of 1.384, which suggesting that the stock is 38.423% more volatile than S&P 500. In comparison Nerds On Site has a beta of 1.690, suggesting its more volatile than the S&P 500 by 68.998%.

Docebo has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nerds On Site offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Docebo pays -- of its earnings as a dividend. Nerds On Site pays out -- of its earnings as a dividend.

Docebo quarterly revenues are $75.6M, which are larger than Nerds On Site quarterly revenues of $2.7M. Docebo's net income of $6.8M is higher than Nerds On Site's net income of -$263.5K. Notably, Docebo's price-to-earnings ratio is 78.81x while Nerds On Site's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Docebo is 7.05x versus 0.56x for Nerds On Site. Usually stocks with elevated PS ratios are considered overvalued.

XTM has a net margin of 8.95% compared to Docebo's net margin of -172.45%. Docebo's return on equity of 27.19% beat XTM's return on equity of --.

Docebo has a consensus price target of $76.17, signalling upside risk potential of 21.59%. On the other hand XTM has an analysts' consensus of -- which suggests that it could fall by --. Given that Docebo has higher upside potential than XTM, analysts believe Docebo is more attractive than XTM.

Docebo has a beta of 1.384, which suggesting that the stock is 38.423% more volatile than S&P 500. In comparison XTM has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Docebo has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. XTM offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Docebo pays -- of its earnings as a dividend. XTM pays out -- of its earnings as a dividend.

Docebo quarterly revenues are $75.6M, which are larger than XTM quarterly revenues of $2.4M. Docebo's net income of $6.8M is higher than XTM's net income of -$4.2M. Notably, Docebo's price-to-earnings ratio is 78.81x while XTM's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Docebo is 7.05x versus 2.37x for XTM. Usually stocks with elevated PS ratios are considered overvalued.